| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| KLRC4-KLRK1 |
P26718
|
KLRC4-KLRK1 readthrough
|
|
|
0.469 |
0.769 |
| H19 |
|
H19 imprinted maternally expressed transcript
|
|
|
0.494 |
0.923 |
| RMRP |
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
|
0.519 |
0.731 |
| IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
| RNU4ATAC |
|
RNA, U4atac small nuclear (U12-dependent splicing)
|
|
|
0.556 |
0.808 |
| ERVW-1 |
Q9UQF0
|
endogenous retrovirus group W member 1, envelope
|
|
|
0.505 |
0.692 |
| IGHG3 |
P01860
|
immunoglobulin heavy constant gamma 3 (G3m marker)
|
|
|
0.513 |
0.769 |
| LOC102723407 |
|
immunoglobulin heavy variable 4-38-2-like
|
|
|
0.514 |
0.769 |
| ERVK-32 |
|
endogenous retrovirus group K member 32, envelope
|
|
|
0.522 |
0.692 |
| ERVK-20 |
|
endogenous retrovirus group K member 20
|
|
|
0.533 |
0.692 |
| LOC102724971 |
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
|
|
0.527 |
0.769 |
| ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
| ERVK-18 |
|
endogenous retrovirus group K member 18
|
|
|
0.560 |
0.654 |
| IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |
| IL12A-AS1 |
|
IL12A antisense RNA 1
|
|
|
0.633 |
0.654 |
| IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
| SCLC1 |
|
small cell cancer of the lung
|
|
|
0.612 |
0.577 |
| TRAC |
P01848
|
T cell receptor alpha constant
|
Receptor
|
|
0.691 |
0.615 |
| MUC16 |
Q8WXI7
|
mucin 16, cell surface associated
|
|
8.3E-112 |
0.479 |
0.808 |
| MYOM2 |
P54296
|
myomesin 2
|
|
7.0E-85 |
0.570 |
0.692 |
| TG |
P01266
|
thyroglobulin
|
Enzyme modulator
|
2.9E-59 |
0.480 |
0.808 |
| TET2 |
Q6N021
|
tet methylcytosine dioxygenase 2
|
|
4.3E-54 |
0.458 |
0.808 |